Cargando…

An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products

The purpose of this study was to predict in vivo performance of three oral products of Etoricoxib (Arcoxia(®) as reference and two generic formulations in development) by conducting in vivo predictive dissolution with GIS (Gastro Intestinal Simulator) and computational analysis. Those predictions we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Alvarez, Isabel, Bermejo, Marival, Tsume, Yasuhiro, Ruiz-Picazo, Alejandro, Gonzalez-Alvarez, Marta, Hens, Bart, Garcia-Arieta, Alfredo, Amidon, Greg E., Amidon, Gordon L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067797/ https://www.ncbi.nlm.nih.gov/pubmed/33917118 http://dx.doi.org/10.3390/pharmaceutics13040507

Ejemplares similares

Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses
por: Bermejo, Marival, et al.
Publicado: (2019)

Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola(®) on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b)
por: Hens, Bart, et al.
Publicado: (2020)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
por: Bermejo, Marival, et al.
Publicado: (2020)

Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola(®) on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566
por: Hens, Bart, et al.
Publicado: (2020)

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
por: Bermejo, Marival, et al.
Publicado: (2020)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
por: González-Álvarez, Isabel, et al.
Publicado: (2022)

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
por: Figueroa-Campos, Andrés, et al.
Publicado: (2020)

Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019)

Predictive Potential of BCS and Pharmacokinetic Parameters on Study Outcome: Analysis of 198 In Vivo Bioequivalence Studies
por: Krajcar, Dejan, et al.
Publicado: (2023)

One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products
por: Prieto-Escolar, Mercedes, et al.
Publicado: (2021)

New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties
por: Mudie, Deanna M., et al.
Publicado: (2020)

The Feasibility of Enzyme Targeted Activation for Amino Acid/Dipeptide Monoester Prodrugs of Floxuridine; Cathepsin D as a Potential Targeted Enzym
por: Tsume, Yasuhiro, et al.
Publicado: (2012)

Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations
por: De Simone, A., et al.
Publicado: (2021)

Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability
por: Tsume, Yasuhiro, et al.
Publicado: (2008)

The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014)

An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence
por: Vlachou, Marilena, et al.
Publicado: (2021)

Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
por: Tsume, Yasuhiro, et al.
Publicado: (2017)

Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization
por: Cao, Fengjuan, et al.
Publicado: (2016)

Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug
por: Leal, Leila Bastos, et al.
Publicado: (2017)

Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs
por: de Souza Teixeira, Leonardo, et al.
Publicado: (2020)

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
por: Meulman, Jessica, et al.
Publicado: (2023)

Get real in individual participant data (IPD) meta‐analysis: a review of the methodology
por: Debray, Thomas P. A., et al.
Publicado: (2015)

Validated HPLC–PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities
por: Abdel Rahman, Mona A., et al.
Publicado: (2022)

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations
por: Fujii, Akira, et al.
Publicado: (2009)

Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study
por: Loh, Gabriel Onn Kit, et al.
Publicado: (2022)

Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies
por: Ozgenc, Emre, et al.
Publicado: (2022)

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
por: Zhang, X, et al.
Publicado: (2017)

Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
por: Tsume, Yasuhiro, et al.
Publicado: (2008)

Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants
por: Heissam, Khaled, et al.
Publicado: (2020)

Development and validation of UV-Visible spectrophotometric baseline manipulation methodology for simultaneous analysis of drotraverine and etoricoxib in pharmaceutical dosage forms
por: Choudhari, Vishnu P., et al.
Publicado: (2011)

Cutaneous Biodistribution: A High-Resolution Methodology to Assess Bioequivalence in Topical Skin Delivery
por: Quartier, Julie, et al.
Publicado: (2019)

Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water
por: Takagi, Toshihide, et al.
Publicado: (2023)

Dissolution Kinetics of a BCS Class II Active Pharmaceutical Ingredient: Diffusion-Based Model Validation and Prediction
por: Gao, Yuan, et al.
Publicado: (2021)

Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence
por: Zhang, X, et al.
Publicado: (2017)

Solubility and Dissolution Enhancement of Etoricoxib by Solid Dispersion Technique Using Sugar Carriers
por: Das, Abhisekh, et al.
Publicado: (2011)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
por: Kus-Slowinska, Marta, et al.
Publicado: (2020)

In vivo magnetic resonance spectroscopy: basic methodology and clinical applications
por: van der Graaf, Marinette
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_k37kgu3kvh3ijadmf0i7n7sd7h